Abbott laboratories pakistan (pvt) limited

3,113 views

Published on

Abbott Laboratories functions, operations and market share.

Published in: Health & Medicine, Business
1 Comment
3 Likes
Statistics
Notes
No Downloads
Views
Total views
3,113
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
108
Comments
1
Likes
3
Embeds 0
No embeds

No notes for slide

Abbott laboratories pakistan (pvt) limited

  1. 1. Presented By :Syed Faraz RizviMBA-II(Karachi University)
  2. 2. IntroductionVision & Mission StatementCore ValuesProductsSWOT AnalysisAchievementsIndustry InfoCompetitorsMarket ShareFinancial Data
  3. 3. A Global Broad-Based Health Care Company.Founded in USA about 120 years ago.Operating In more than 130 Countries with over70,000 Employees.Business OperationsPharmaceuticalsNutritionalDiagnosticsDiabetes Care
  4. 4. Abbott Pakistan is a part of the GlobalHealth Care Corporation of AbbottLaboratories, Chicago, USA.Started operations in Pakistan in 1948.Along with 1500 Employees with 2Locations Abbott is discovering newMedicinesTechnologiesWaysTo manage „Health‟
  5. 5. “To be a premier healthcarecompany in Pakistan”
  6. 6. „A Promise for Life‟Turning Science into Caring
  7. 7. Pioneering Leading edge Science &CommercializationAchieving World-Class Execution.Caring Making a difference in people‟s lives.Enduring Commitment & purpose.
  8. 8. Manufacturing more than 160 productsA broad range Including Pharmaceutical Products General Health Care Products Nutritional Products Diagnostics Products Diabetes Care
  9. 9. Pharmaceuticals Products
  10. 10. General Health CareProducts
  11. 11. Nutritional Products
  12. 12. Diagnostics Products
  13. 13. Diabetes Care
  14. 14. Abbott acquired Knoll BASF Pharma in2000 for $6.9 billion.On June 2005 Abbott achieved class „A‟accreditation against Oliver Wight ABCDchecklist.
  15. 15. StrengthsGood company ReputationStrong Distribution NetworkStrong Brand positioningDeep roots in Pharma businessProfessional Management Team
  16. 16. WeaknessesComparatively High PricesRelying on Imported Raw MaterialLacking of deep rural penetration
  17. 17. OpportunitiesA part of high potential EconomyHigh rate of population increase inPakistanIncreasing Healthcare awareness
  18. 18. ThreatsHigh Inflation rateForeign exchange ratePolitical condition of PakistanGovt restriction on price
  19. 19. The Pakistan pharmaceutical industry meetsaround 70% of the country‟s demand offinished medicineWith an export turnover of over US $ 100million as of 2007.Market Share divided into 59% Local 41%multinational
  20. 20. 7.64.33.95.9012345678GSK Highnoon Labs Getz Pharma Abbott LabMarket ShareGSKHighnoon LabsGetz PharmaAbbott Lab59% Local 41% multinationalSOME MAJOR PLAYERS IN PHARMA INDUSTRY
  21. 21. 1st Qtr21%2nd Qtr43%3rd QtrAug,201036%4th Qtr0%Sales 2010YEAR PROFIT AFTER TAXATION(3rd Quarter)31 Aug-2010 Rs. 315,000,000(2nd Quarter & Half ended) May31st, 2010.Rs. 339,047,000(1st Quarter) February 28, 2010. Rs. 184,519,000
  22. 22. YEARS TOTAL SALES(Rs in 000)PROFIT Rs 000(after taxation)Net Profit toSales %2009 8,450,118 825,676 9.82008 7,123,412 343,980 4.82007 6,584,454 1,184,762 18.02006 5,914,181 1,000,008 16.99.80%4.80%18%16.90%0.00% 5.00% 10.00% 15.00% 20.00%2009200820072006Net Profit to SalesNet Profit to Sales %
  23. 23. 38.50%22.41%0.03%44.35%0.10%To EmployeesTo GovernmentTo SocietyTo Providers ofCapitalTo Providers ofFinance2009 Spendings2009
  24. 24. •No Doubt upon Company‟s ability toContinue as a going concern.•Assets Rs. 4.9 Billion(2009)•Cash in Hand only Rs. 770 Million(2009)

×